Frequent hepatic steatosis in amyotrophic lateral sclerosis: Implication for systemic involvement

Neurology and Clinical Neuroscience

Volumn 3, Issue 2, 2015, Pages 58-62

  Nodera, Hiroyuki ^a   Takamatsu, Naoko ^a,b   Muguruma, Naoki ^a   Ukimoto, Kazuhiro ^b   Nishio, Susumu ^c   Oda, Masaya ^b   Izumi, Yuishin ^a,b   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Department of Neurology   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Hepatic steatosis; Lipid metabolism; Neurodegeneration; Sonography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL;

EID: 84974548868     PISSN: None     EISSN: 20494173     Source Type: Journal    
DOI: 10.1111/ncn3.143     Document Type: Article

References (17)

1. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve 2011; 44: 20-4.
2. Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 2011; 258: 613-7.
3. Dupuis L, Corcia P, Fergani A et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004-9.
4. Chio A, Calvo A, Ilardi A et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 2009; 73: 1681-5.
5. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011; 10: 75-82.
6. Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study. Intern. Med. 2012; 51: 1501-8.
7. Shimizu T, Nagaoka U, Nakayama Y et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph. Lateral Scler. 2012; 13: 363-6.
8. Schmitt F, Hussain G, Dupuis L, Loeffler JP, Henriques A. A plural role for lipids in motor neuron diseases: Energy, signaling and structure. Front. Cell. Neurosci. 2014; 8: 25.
9. Finkelstein A, Kunis G, Seksenyan A et al. Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS ONE 2011; 6: e22374.
10. Hamaguchi M, Kojima T, Itoh Y et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 2007; 102: 2708-15.
11. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World J. Gastroenterol. 2008; 14: 3476-83.
12. Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 2011; 54: 1082-90.
13. Eguchi Y, Hyogo H, Ono M et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: A multicenter large retrospective study. J. Gastroenterol. 2012; 47: 586-95.
14. Cimini S, Rizzardini M, Biella G, Cantoni L. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. J. Neurochem. 2014; 129: 413-25.
15. Allen SP, Rajan S, Duffy L et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol. Aging 2014; 35: 1499-509.
16. Kohjima M, Enjoji M, Higuchi N et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2007; 20: 351-8.
17. Heck MV, Azizov M, Stehning T, Walter M, Kedersha N, Auburger G. Dysregulated expression of lipid storage and membrane dynamics factors in Tia1 knockout mouse nervous tissue. Neurogenetics 2014; 15: 135-44.